Ok, today was a little bit better with some news to report, like Lo Bosworth pushing Yaz and Sepracor canning almost 1000 people!!! Yikes! Anyway, let’s see what else happened today:

*Seattle Genetics has sold $55M worth of stock to advance their cancer mAb SGN-35. [Xconomy]

*There’s a new drug for overactive bladder: Watson’s topical oxybutynin gel. [FierceBiotech]

*The FDA is ready to review Savient’s gout drug. Watch out for this one – safety issues! [Forbes]

*Exact Sciences goes with Genzyme, scraps deal with Sequenom. [Reuters UK]

*Diagnostics player 23andMe, funded by Google and Genentech, enters rare disease collaboration with mondoBIOTECH. [BioSpace]

*Synvista Therapeutics is scrapping all of there drug development programs. [Yahoo!Finance]

Let’s see what happens on Thursday…

Image from emofaces

Related Posts